Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Immuron Says Receives FDA Approval For Travelan IND Application

FDA
News

Immuron Says Receives FDA Approval For Travelan IND Application

-Reuters

byMichael Horton

December 22, 2022

1 minute read

-Reuters

Vertex’s Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs

By Vandana Singh

February 6, 3:55 PM

Vertex Pharmaceuticals' cystic fibrosis treatment with vanza triple therapy. SKYLINE trials show non-inferiority to Trikafta, emphasizing once-daily dosing benefits.

VRTX

News

Gorilla Technology And Thames Freeport Announce Strategic Alliance, Advancing Smart City Innovations And Fostering Trade Partnerships

By Benzinga Newsdesk

April 10, 8:06 AM

Gorilla Technology Group Inc. ("Gorilla") (NASDAQ:GRRR), a global leader in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology, today announced they have signed a Memorandum of

GRRR